Last reviewed · How we verify

benzathine phenoxymethylpenicillin — Competitive Intelligence Brief

benzathine phenoxymethylpenicillin (benzathine phenoxymethylpenicillin) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: benzathine phenoxymethylpenicillin. Area: Infectious Disease.

unknown benzathine phenoxymethylpenicillin Infectious Disease Live · refreshed every 30 min

Target snapshot

benzathine phenoxymethylpenicillin (benzathine phenoxymethylpenicillin). Benzathine phenoxymethylpenicillin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
benzathine phenoxymethylpenicillin TARGET benzathine phenoxymethylpenicillin unknown benzathine phenoxymethylpenicillin

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (benzathine phenoxymethylpenicillin class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). benzathine phenoxymethylpenicillin — Competitive Intelligence Brief. https://druglandscape.com/ci/benzathine-phenoxymethylpenicillin. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing